US FDA declines to authorise antidepressant fluvoxamine for Covid - 1breakingnews.com

  • 2 years ago
New York, May 17 (SocialNews.XYZ) The US Food and Drug Administration has declined to approve antidepressant fluvoxamine as a treatment for Covid-19 as data is insufficient to conclude its effectiveness against the virus. Fluvoxamine has.

VIEW MORE : https://bit.ly/1breakingnews

Recommended